Safety and Efficacy Study of LX103 Treatment of X-Linked Retinoschisis (XLRS)
Condition: X-linked Retinoschisis · Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
About this study
The goal of this study is to evaluate the safety and efficacy of LX103 treatment of X-linked retinoschisis. This study will enroll subjects aged ≥ 6 years old to receive a single unilateral intravitreal (IVT) injection of LX103 to evaluate its safety and efficacy.
This description comes directly from the study's public registry record.
Talk to the study team
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
Locations (1)
| Shanghai General Hospital, Shanghai Jiao Tong University | Shanghai, China | Recruiting |
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05814952